Applicant, as named in the Orange Book

Btg Intl

Next listed expiry: Vistogard on 17 Aug 2027. 2 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Vistogard uridine triacetate	uridine triacetate	208159	17 Aug 2027	patent, carve-out possible
Aurlumyn iloprost	iloprost	217933	18 Jul 2044	patent, carve-out possible

24 Oct 2026Vistogard · Enters 12-month window basis: patent, carve-out possible17 Aug 2027

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Cyanokit hydroxocobalamin	hydroxocobalamin	022041	open now	no listed protection
Xuriden uridine triacetate	uridine triacetate	208169	open now	no listed protection